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Abstract: Antibacterial activity of bifidobacteria isolated from Mongolian infant faeces was elucidated on 
pathogenic intestinal bacteria for the development of a new antibacterial bifidobacteria, the permission 
for which was granted by the Mongolian Medical Ethics Committee Approval (MMECA). A total of forty-
nine single colonies were obtained from 3 samples by using a BL medium enrichment. Among them, 29 
isolates had Gram−positive, catalase−negative properties, and maul−like or Y−shaped morphology, 
and then, 20 Bifidobacterium breve and 9 Bifidobacterium longum strains were detected by the B. breve 
and B. longum specific primers. Organic acids produced by the isolated bifidobacteria in their cell-free 
supernatants were quantitatively analyzed by a spectrophotometric absorbance at 340 nm, suggesting that 
D−lactic, L−lactic, and acetic acids were produced, and the pH of the supernatants was at 3.86−4.55. The 
isolated bifidobacteria showed antibacterial activity toward Escherichia coli and Salmonella typhimurium 
as high as that of a standard bifidobacteria, however, lower activity against Staphylococcus aureus. The 
antibacterial activity was probably due to the production of organic acids.




Bifidobacteria with Gram−positive and 
catalase−negative properties are known to 
have a potent antibacterial activity due to the 
production of organic acids such as lactic and 
acetic acids [1−6]. Bifidobacteria are found 
in the intestinal tract of humans and animals 
[7, 8] and work as probiotics for promoting 
health [9]. Although the antibacterial activity 
of bifidobacteria is usually expressed by 
the produced organic acids, peptides called 
bacteriocin are also involved [4,10-15]. 
Several papers appeared on the antibacterial 
activity of bifidobacteria with the production 
of organic acids. Makras and Vuyst found 
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astrong antibacterial activity of bifidobacteria 
towards Gram−negative bacteria, Salmonella 
and E. coli strains, with the production of lactic 
and acetic acidsand reported the inhibition of 
growth of Gram−positive bacteria with the 
production of a bacteriocin [16]. The agar 
plate spot test of bifidobacteria on several 
pathogenic bacteria showed antibacterial 
activity and one of the main inhibitory reasons 
was reported by the production of organic 
acids[5]. Georgieva described the comparison 
of acidic and neutralized cell−free supernatants 
cultured by bifidobacteria, indicating that 
the acidic supernatant was active on several 
pathogenic bacteria and the neutralized 
supernatant also showed antibacterial activity. 
In brief, the activity against Gram-positive 
pathogens is mostly due to the bactericidal 
effect of protease sensitive bacteriocins, 
while the antagonistic effects towards Gram-
negative pathogens could be related to the 
production of organic acids and hydrogen 
peroxide[17]. Biedrzycka reported that lactic 
and acetic acids were main the products of 
bifidobacteria fermentation with sugar. The 
highest amount of lactic and acetic acids was 
obtained from the fermentation  of lactose 
determined by gas chromatography analysis 
[18]. As mentioned above, strong antibacterial 
activity of bifidobacteria was mainly caused by 
the production of organic acids. Recently, we 
showed the antibacterial activity of lactic acid 
bacteria (LAB), L. hilgardii and L. diolivorans, 
which were isolated from the traditional 
fermented mare’s milk - airag, in Mongolia 
and identified by the 16S rDNA analysis [19]. 
Although the antibacterial activity of LAB 
was due to the production of organic acids, 
antibacterial peptides were also contained in 
the fermented supernatant. 
In this work, we isolated and identified several 
bifidobacteria from faeces of Mongolian 
infants 0−6 months of age by specific primers 
for B. breve and B. longum to select potent 
antibacterial strains. The antibacterial activity 
was evaluated by the ability of lactic and 
acetic acid productions and by the inhibition 
of multiplication on pathogenic strains, 
Escherichia coli, Staphylococcus aureus, and 
Salmonella typhimurium.  We also, determined 
the ability of organic acids production by 
carbohydrate fermentation of the isolated 
bifidobacteria.
MATERIALS AND METHODS
Materials: Gifu anaerobic medium 
(GAM), blood liver medium (BLM), De 
Man Rogasa and Shape (MRS) broth, and 
trypticase soy broth (TSB) were purchased 
from Nippon Suisan Kaisha, Ltd (Tokyo, 
Japan) and Becton, Dickinson and Company 
(Erembadgem, Belgium), respectively. 
Anaero pack and QIAamp DNA mini kit 
were obtained from Mitsubishi Gas Chemical 
Co. Ltd., (Tokyo, Japan) and QIAGEN. V. 
(Hilden, Germany), respectively. Standard 
bifidobacteria, Bifidobacterium adolescents, 
Bifidobacteriumlongum, and Bifidobacterium 
breve, were available from Japan Collection of 
Microorganism (Tsukuba, Japan). Pathogenic 
strain, Escherichia coli 1099, Staphylococcus 
aureus 1045, and Salmonella typhimurium 
1098, was used from the stock strains at the 
Mongolia Institute of Veterinary Medicine. 
Enzymatic Bioanalysis / Food Analysis UV 
method kit (EBFA kit) was purchased from 
R−Biopharm AG (Darmstadt, Germany).
Isolation of bifidobacteria: Three samples 
of faeces of Mongolian infants aged from 0 to 
6 months were collected with the permission 
of the Mongolian Medical Ethics Committee. 
Bifidobacteria were isolated from the faeces 
samples according to the direct plating 
method. Each faeces sample (about 1 g) was 
collected in a sterile sampling tube (5 ml) and 
then kept at 4°C until use. The faeces (0.1 g) 
were diluted by a trypticase soy broth (TSB) 
(10 mL) after which the mixture was well 
stirred. The sample (0.1 mL) was spread on 
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an agar prepared with a blood liver medium 
(BLM), which is a medium for bifidobacteria 
incubation. After the agar plate was incubated 
for 3 days at 37°C under anaerobic condition, 
several colonies appeared. 
Each colony on the agar plate was recultured 
on a new GAM agar plate and then the new 
plate was anaerobically cultured for 2 days at 
37°C. This procedure was repeated 3 times to 
give pure single colonies. The obtained single 
colony was examined by a Gram−staining, 
catalase activity, and microscope observation 
to obtain 29 bifidobacteria with Gram−positive, 
catalase−negative characters, and maul−like or 
Y−shaped morphological structure. 
DNA extraction and identification of 
bifidobacteria: The GAM broth culture of 
single colony as described above (1 mL) was 
fractionated into a micro centrifuge tube (1.5 
mL) and then the tube was centrifuged for 5 
min at 5000G. Precipitated bifidobacterium 
was collected and then DNA was extracted by 
using a QIAamp DNA mini kit.
Identification of the isolated bifidobacterium 
was performed by a PCR using 16S 
rDNA analysis. Typical procedure for the 
PCR using specific primers, BiBRE−1 
( 5 ’ - C C G G A T G C T C C A T C A C A C - 3 ’ ) 
and BiBRE−2 
(5’-ACAAAGTGCCTTGCTCCCT-3’), for 
B. breve [20] was as follows. In a PCR tube, 
the primer solution (0.1µL each), DNTP 1 
µL, 10×Taq EX 1 µL, Takara EX Tag (0.05 
µL), water (6.55µL), and template DNA 1 
µL (>100 ng) was added, and the PCR tube 
was placed in a thermal cycler. The following 
was programmed for the amplification of 
16S rDNA. The tube was heated for 5 min at 
94°C as an initial denaturation step and then 
35 cycles for 30 sec at 94°C for denaturation, 
20 sec at 50°C for annealing, and 0.5 min at 
72°C for elongation, respectively. Lastly, the 
tube was kept for 5 min at 72°C for the final 
extension step. The amplification product 
was confirmed by a Mupid electrophoresis on 
1.2% agarose gel, which was then stained by 
ethidium bromide solution. B. longum strain 




by the same procedure as above.
Quantitative analysis of organic acids in 
bifidobacteria cultured solution: A typical 
procedure for measuring the concentration 
of organic acid in the incubation supernatant 
is as follows. The mixture of INFbre 1 (B. 
breve) (no. 1 in Table 1) (20×109 cell/mL) in 
GAM (10 mL) broth containing 2% of glucose 
supplement was anaerobically incubated 
for 3 days at 37°C. The pH of the mixture 
was 3.86. The concentration of lactic and 
acetic acids produced in the supernatant was 
quantitatively determined by an EBFA−kit 
using a spectrophotometer measured at 340 
nm according to the maker provided protocol 
to give 0.06 g/L of D−lactic acid, 6.02 g/L 
of L−lactic acid, and 6.74 g/L of acetic acid, 
respectively [21].
Carbohydrate fermentation test: A typical 
procedure for carbohydrate fermentation 
was as follows. INFbre 1 (20×109 cell/mL) 
in GAM broth (4 mL) was fermented in a 10 
mL of glass tube for 24 hours at 37°C to give 
fermented products. After centrifugation, the 
cell free supernatant was discarded, and then 
PBS broth (0.9%, 3 mL) was added to the 
tube. The mixture was suspended by using a 
vortex shaker and then a small amount of the 
mixture (0.02 mL) was inoculated to a 10 ml 
of glass tube containing glucose (0.5 g) and 
Bromocresol purple in GAM broth (4 mL) 
without dextrose. After incubation for 48 hours 
at 37°C, the color of the mixture changed from 
yellow to violet. The degree of color changing 
was measured by a spectrophotometer at 340 
nm. The fermentation ability was compared 
to that of a standard bifidobacteria B. breve 
JCM01192 that showed (+) for fermentation, 
(-) for no fermentation, and (w) for weak 
fermentation, respectively.
Antibacterial activity test: A typical 
procedure for the antibacterial activity on 
Escherichia coli 1099 was as follows. 
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INFbre 1 (20×109 cell/mL in2µL of MRS 
broth) was inoculated on an MRSagarplate 
and then incubated for 24 hours at 37°C to 
appear a colony at the spotted point. E. coli 
(1×1012 cell/mL, 20 µL) with 10 ml of TSB 
broth containing 0.8 % agar was overlaid at 
45°C on the INFbre 1 spotted agar plate, and 
then the plate was aerobically incubated at 
37°C. The diameter of a clear zone around the 
spot was measured after 24, 48, and 72 hours 
respectively to show the antibacterial activity 
of the isolated bifidobacterium. Commercially 
available Staphylococcus aureus 1045  and 
Salmonella typhimurium 1098, respectively, 
were also used as control bacteria for the 
antibacterial activity test and the results are 
shown in Table 3 and Figure 1.
RESULTS AND DISCUSSION
Isolation of B. breve and B. longum 
bifidobacteria from infant faeces: 49 single 
colonies were obtained on the agar plate 
medium from the faeces collected from 3 
Mongolian infants. From among them, 20 
colonies showed Gram−negative and rod−
like shapes, indicating that these strains were 
not bifidobacteria. The remaining 29 colonies 
had Gram−positive and catalase−negative 
properties and showed the cell morphology 
like maul or Y shaped short rod when observed 
under a microscope, suggesting that these 
29 colonies were bifidobacteria. These 29 
single colonies were detected by using the 
most common bifidobacteria specific primers 
of 16S rDNA, BiBRE−1 and BiBRE−2 for 
B. breve and BiLON−1 and BiLON−2 for 
B.longum, indicating that 20 B. breve and 9 
B. longum strains were obtained. These two 
kinds of bifidobacteria are known to have 
potent antibacterial activity. Therefore, several 
bifidobacteria that produced a large amount 
of organic acids were selected from the 29 
bifidobacteria strains.
Table 1 shows the results of organic acid 
production in the supernatant by the 29 
bifidobacteria
Table 1. Production of organic acids by isolated bifidobacteriaa
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a Incubation of bifidobacteria (20×109 cell/mL) was performed in 2% glucose containing 
GAM broth (100 mL) for 72 hours at 37°C.
b pH was determined after 3 days in liquid medium by using pH meter 
c The concentration of organic acids in the cell-free supernatant were determined by a 
commercially available F-kit and an UV absorbance at 340 nm for D-lactic, L-lactic, and 
acetic acids, respectively.
d Bifidobacteria were identified by a PCR using bifidobacteria specific primers.
(20×109 cell/mL) after incubation in GAM 
broth (4 mL) with 2% glucose for 72 hours 
at 37°C. After incubation, the pH of the cell-
free supernatant decreased at 3.86−4.55, 
respectively, and the B. breve supernatants 
had pH values relatively lower than those of 
B. longum. Among the organic acids produced 
by the bifidobacteria, D−lactic, L−lactic, and 
acetic acids were mainly produced by the 
metabolites of glucose. The organic acids were 
quantitatively analyzed by using an EBFA−
kit, which gave the concentration of these 
organic acids measured by the absorbance 
at 340 nm. The production of organic acids 
was a good evidence for the antibacterial 
activity of bifidobacteria toward Gram−
negative pathogenic bacteria [18]. D−Lactic 
acid was produced in lower proportion in the 
supernatant than that of L−lactic acid.
Carbohydrate fermentation ability: 
Carbohydrate fermentation ability of 
bifidobacteria was examined by using several 
carbohydrates. The results are demonstrated in 
Table 2. 
Table 2. Fermentation of isolated bifidobacteria with carbohydratea
Carbohydrate
Isolated B. breve strain B.longum
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a  Fermentation ability of bifidobacteria was evaluated at three levels, (+) Positive, (w) weak 
but positive, and (-) negative.
Lactic and acetic acids were obtained as 
a result of metabolism. The fermentation 
ability was evaluated at three levels, (+) 
positive, (w) weak but positive, and (-) 
negative, and measured by the color changes 
of the fermented supernatant due to the 
concentration of organic acids determined 
by the absorbance at 340 nm. Bifidobacteria 
with relatively higher ability of acetic acid 
production were selected and bifidobacteria 
with lower production of acetic acid, 4.31 
g/L (INFBre 12) and 4.43 g/L (INFLon 24), 
were also selected for the comparison of 
the fermentation ability. Although pentoses 
expectribose was not fermented by the 
isolated B.breve, arabinose was fermented 
by B.longum to give organic acids. Hexoses, 
disaccharides, and alditols expectinositol were 
fermented by all tested strains belonging to 
both species. A polysaccharide starch and 
glycosides were fermented by the B. breve 
strains, but it was either not fermented, or 
the fermentation was weak by using the B. 
longum strains. The fermentation ability of 
both bifidobacteria on rhamnose, sorbose and 
inositol was low. Melicitose was fermented 
only by B.longum. These results indicate that 
the isolated bifidobacteria fermented mainly 
hexoses and disaccharides to produce organic 
acids. The INFbre 2, 3, and 12 strains were 
found to have strong fermentation ability. On 
the other hand, B. longum strains had relatively 
weak fermentation ability. Xylose was only 
fermented by the INFlon 24 B. longum strain.
Antibacterial activity toward E. coli, S. 
aureus, and S. typhimurium: Antibacterial 
activity of the isolated bifidobacteria toward 
the pathogenic strains, E. coli, S. aureus, and 
S. typhimurium, was performed by an agar spot 
test. Figure 1 shows the results of the agar spot 
test of INFbre 11 (B. Breve) and INFlon 22 (B. 
longum) toward E. coli, and S. typhimurium, in 
which an inhibition (clear) zone was compared 
with that of the standard bifidobacteria, B. 
Breve 01192 and B. longum 01217 strains. 
INFbre 11 and INFlon 22 bifidobacteria were 
spotted on the agar plate, respectively, and 
then pathogenic strains were overlaid on the 
bifidobacteria plates. After incubation for 72 
hours at 37°C, the clear zone without E. coli 
and S. typhimurium appeared, indicating that 
the bifidobacteria inhibited the multiplication 
of the pathogenic bacteria. 
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Figure 1. Antibacterial activity of isolated bifidobacteria toward Gram−negative pathogenic bacteria (A) 
E. coli and (B) S. typhimurium. (a) INFbre 11, (b) INFlon 22, (c) B. breve 01192, and (d) B. longum 01217. 
The pathogenic bacteria was overlaid on the isolated bifidobacteria agar plate, respectively, to appear 
clear zones.
The diameter of the clear zone was measured 
and compared with that of the standard 
bifidobacteria, indicating that both isolated 
bifidobacteria, INFbre 11 and INFlon 22, were 
found to have potent antibacterial activity on 
E. coli and S. typhimurium as high as that of 
the standard bifidobacteria. The diameter was 
more than 10 mm and 17 mm for E. coli and S. 
typhimurium, respectively. As shown in Table 
3, the isolated B. longum strain INFlon 22 was 
found to show potent anti- 
Table 3. Antibacterial activity of isolated bifidobacteria on pathogenic bacteriaa
Bifidobacteria
Pathogen
E. coli S.aureus S.typhimurium









































a  Antibacterial activity was carried out by an agar spot test [4]. 
 The evaluation was as follows. (-): no inhibition, (±): below 10 mm of the inhibited zone 
with unclear halo, (+): below 10 mm of the inhibition zone with clear halo, (++): below 17 
mm of the inhibition zone with clear halo, and (+++): more than 17 mm of the inhibition 
zone with clear halo.
bacterial activity toward E. coli and S. 
typhimurium, and the B. breveI NFbre 11 
strain showed medium or higher antibacterial 
activity. However, both isolated bifidobacteria 
did not inhibit the multiplication of S. aureus, 
because the clear zone did not appear. 
The antibacterial activity of the isolated 
bifidobacteria in this work was attributed to 
the production of organic acids such as lactic 
and acetic acids. Other isolated bifidobacteria 
in Table 1 also showed antibacterial activity on 
the pathogenic strains.
Proceedings of the Mongolian Academy of Sciences Vol. 58 No 01 (225) 2018
- 51 -
PMAS
Proceedings of the Mongolian Academy of Sciences https://www.mongoliajol.info/index.php/PMAS
Vol. 58 No 03 (227) 2018
DOI: https://doi.org/10.5564/pmas.v58i3.1034
CONCLUSIONS
We isolated and identified several bifidobacteria 
from Mongolian infant faeces by using the 
B. breve and B. longum specific primers 
and the antibacterial activity of the isolated 
bifidobacteria was investigated. The pH value 
of the cell-free supernatant ranged from 3.86 to 
4.55, due to the production of lactic and acetic 
acids, which were quantitatively analyzed by 
the absorbance measurement at 340 nm using 
the commercially available EBFA−kit. The 
isolated INFbre 11 bifidobacterium was found 
to produce the highest concentration of L−
lactic (15.67 g/L) and acetic (6.59 g/L) acids, 
respectively. The INFbre 20 B. breve strain 
also produce high concentration of L−lactic 
acid (15.63 g/L), but lower acetic acid (0.30 
g/L). The isolated bifidobacteria, INLbre 11 
and INFlon 22 gave clear zones on the E. coli 
and S. typhimurium agarplates respectively, 
as large as that of the standard bifidobacteria, 
indicating that the isolated bifidobacteria had 
potent antibacterial activity probably due to 
the production of organic acids. In addition, 
the isolation of antibacterial peptides produced 
by the isolated bifidobacteria is under 
investigation.
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